Basilard BioTech's Celletto™ technology is a superior, nonviral nanomechanical-based gene delivery tool for use in the cell and gene therapy markets.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free